Reply to Applicability of the Oral Glucose Tolerance Test in Assessing Prevalence and Incidence of Diabetes Mellitus in Schizophrenia

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We appreciate the comments of Dr. Cohen on our study. Our study in the first place is a clinical monitoring routine, of which the results are systematically being collected and analyzed. More specifically, the vast majority of patients treated with antipsychotic medication in our hospital and affiliated services are being screened and monitored for metabolic abnormalities. This screening routine was started in November 2003, and inclusions have been ongoing since then.’ ‹